{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:08:49Z","timestamp":1784214529439,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY025093"],"award-info":[{"award-number":["EY025093"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.xops.2023.100437","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T13:57:56Z","timestamp":1700747876000},"page":"100437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of Intermediate-Stage Age-Related Macular Degeneration with Plasma Inflammatory Biomarkers in Persons with AIDS"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0368-1361","authenticated-orcid":false,"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Won","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Beck-Engeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle C.","family":"Ambayec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2023.100437_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xops.2023.100437_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/323898","article-title":"Clinical indicators of immune restoration following highly active antiretroviral therapy","volume":"34","author":"Cooney","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xops.2023.100437_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xops.2023.100437_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2010.10.018","article-title":"Cytomegalovirus retinitis and the acquired immunodeficiency syndrome\u2013bench to bedside: LXVII Edward Jackson Memorial Lecture","volume":"151","author":"Jabs","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib5","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/01.aids.0000189864.90053.22","article-title":"Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004","volume":"19","author":"Schneider","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.xops.2023.100437_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7326\/0003-4819-146-2-200701160-00003","article-title":"Survival of persons with and without HIV infection in Denmark, 1995-2005","volume":"146","author":"Lohse","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xops.2023.100437_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","author":"Hogg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2023.100437_bib8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/521935","article-title":"Ten-year predicted coronary heart disease risk in HIV-infected men and women","volume":"45","author":"Kaplan","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xops.2023.100437_bib9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xops.2023.100437_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.xops.2023.100437_bib11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/gerona\/glt168","article-title":"Is HIV a model of accelerated or accentuated aging?","volume":"69","author":"Pathai","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.xops.2023.100437_bib12","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4049\/jimmunol.180.3.1499","article-title":"Homeostasis of the naive CD4+ T cell compartment during aging","volume":"180","author":"Kilpatrick","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.xops.2023.100437_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-407707-2.00002-3","article-title":"Immune dysregulation syndrome in treated HIV infection","volume":"119","author":"Lederman","year":"2013","journal-title":"Adv Immunol"},{"key":"10.1016\/j.xops.2023.100437_bib14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ajo.2015.01.037","article-title":"Prevalence of intermediate-stage age-related macular degeneration in patients with the acquired immunodeficiency syndrome","volume":"159","author":"Jabs","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2017.05.004","article-title":"Incidence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome","volume":"179","author":"Jabs","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib16","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2014.06.014","article-title":"Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections","volume":"121","author":"Kempen","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.xops.2023.100437_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/QAD.0000000000003104","article-title":"Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS","volume":"36","author":"Jabs","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.xops.2023.100437_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","article-title":"Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2023.100437_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0002-9394(01)01218-1","article-title":"The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6","volume":"132","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib20","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17","volume":"123","author":"Davis","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib21","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.xops.2023.100437_bib22","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/infdis\/jiu254","article-title":"Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment","volume":"210","author":"Tenorio","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.xops.2023.100437_bib23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/ciw409","article-title":"Inflammatory biomarkers and mortality risk among HIV-suppressed men: a multisite prospective cohort study","volume":"63","author":"Wada","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xops.2023.100437_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"Wada","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.xops.2023.100437_bib25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ophtha.2006.07.065","article-title":"Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2023.100437_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ajo.2018.12.002","article-title":"Association of age-related macular degeneration with mortality in patients with acquired immunodeficiency syndrome: role of systemic inflammation","volume":"199","author":"Jabs","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.xops.2023.100437_bib28","series-title":"Risk Assessment and Evaluation of Predictions","first-page":"3","article-title":"Non-proportionality of hazards in the competing risk framework","author":"Munoz","year":"2013"},{"key":"10.1016\/j.xops.2023.100437_bib29","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2023.100437_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1047-2797(98)00049-0","article-title":"High levels of plasma C-reactive protein and future risk of age-related cataract","volume":"9","author":"Schaumberg","year":"1999","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.xops.2023.100437_bib31","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1167\/iovs.09-4063","article-title":"C-reactive protein and age-related macular degeneration and cataract: the Singapore Malay Eye Study","volume":"51","author":"Boey","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100437_bib32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/infdis\/jir134","article-title":"Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death","volume":"203","author":"Boulware","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.xops.2023.100437_bib33","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/infdis\/jiw263","article-title":"Plasma soluble CD163 level independently predicts all-cause mortality in HIV-1-infected individuals","volume":"214","author":"Knudsen","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.xops.2023.100437_bib34","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/infdis\/jix113","article-title":"Immunologic pathways that predict mortality in HIV-infected Ugandans initiating antiretroviral therapy","volume":"215","author":"Lee","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.xops.2023.100437_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jlb.63.6.658","article-title":"Overview of interleukin-18: more than an interferon-gamma inducing factor","volume":"63","author":"Dinarello","year":"1998","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.xops.2023.100437_bib36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"Proteolytic processing of interleukin-1 family cytokines: variations on a common theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.xops.2023.100437_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.it.2011.01.003","article-title":"Inflammasome activation and IL-1\u03b2 and IL-18 processing during infection","volume":"32","author":"Van de Veerdonk","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.xops.2023.100437_bib38","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1172\/JCI90699","article-title":"TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies","volume":"127","author":"McGeough","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.xops.2023.100437_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xops.2023.100437_bib40","first-page":"1413","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.xops.2023.100437_bib41","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2023.100437_bib42","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xops.2023.100437_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2012.05.005","article-title":"Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells \u2013 implications for age-related macular degeneration (AMD)","volume":"147","author":"Kauppinen","year":"2012","journal-title":"Immunol Lett"},{"key":"10.1016\/j.xops.2023.100437_bib44","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.celrep.2013.08.002","article-title":"NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration","volume":"12","author":"Marneros","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.xops.2023.100437_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-17121-0_9","article-title":"The NLRP3 inflammasome and its role in age-related macular degeneration","volume":"854","author":"Ildefonso","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.xops.2023.100437_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/tvst.9.13.27","article-title":"Inflammasome proteins as inflammatory biomarkers of age-related macular degeneration","volume":"9","author":"Weaver","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2023.100437_bib47","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kluck","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.xops.2023.100437_bib48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib49","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","article-title":"A\u00a0simplified severity scale for age-related macular degeneration: AREDS Report No. 18","volume":"123","author":"Ferris","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib50","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1167\/iovs.15-17440","article-title":"Nucleoside reverse transcriptase inhibitors suppress laser-induced choroidal neovascularization in mice","volume":"56","author":"Mizutani","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2023.100437_bib51","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022751118","article-title":"Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration","volume":"118","author":"Fukuda","year":"2021","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.xops.2023.100437_bib52","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/QAI.0000000000002466","article-title":"Long-acting injectable cabotegravir\u00a0+ rivaripine for HIV maintenance therapy: week 48 pooled analysis of phase 3 ATLAS and FLAIR trials","volume":"85","author":"Rizzardini","year":"2020","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.xops.2023.100437_bib53","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly","volume":"106","author":"Harris","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.xops.2023.100437_bib54","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jamaophthalmol.2013.2303","article-title":"C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts","volume":"131","author":"Mitta","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib55","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archopht.122.7.1013","article-title":"Monocyte activation in patients with age-related macular degeneration; a biomarker of risk for choroidal neovascularization?","volume":"122","author":"Cousins","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2023.100437_bib56","doi-asserted-by":"crossref","unstructured":"Nassar K, Grisanti S, Elfar E, et\u00a0al. Serum cytokines as biomarkers for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2103;253:699\u2013704.","DOI":"10.1007\/s00417-014-2738-8"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914523001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914523001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:08:34Z","timestamp":1753816114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914523001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2666914523001690"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2023.100437","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Intermediate-Stage Age-Related Macular Degeneration with Plasma Inflammatory Biomarkers in Persons with AIDS","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2023.100437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100437"}}